MKS Instruments, Inc. (NASDAQ:MKSI) has earned an average recommendation of “Buy” from the eleven analysts that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and ten have issued a buy recommendation on the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $112.11.

MKSI has been the topic of several research analyst reports. BidaskClub raised MKS Instruments from a “hold” rating to a “buy” rating in a research note on Wednesday. ValuEngine upgraded shares of MKS Instruments from a “hold” rating to a “buy” rating in a research note on Tuesday, August 6th. Zacks Investment Research lowered shares of MKS Instruments from a “hold” rating to a “sell” rating and set a $94.00 price target on the stock. in a report on Thursday, July 25th. Finally, Susquehanna Bancshares assumed coverage on shares of MKS Instruments in a research report on Wednesday, May 15th. They set a “positive” rating and a $123.00 price objective for the company.

In other MKS Instruments news, Director Jacqueline F. Moloney sold 603 shares of the firm’s stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $81.98, for a total value of $49,433.94. Following the transaction, the director now directly owns 7,692 shares of the company’s stock, valued at $630,590.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 1.24% of the stock is currently owned by corporate insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Invesco Ltd. grew its stake in MKS Instruments by 171.9% in the 2nd quarter. Invesco Ltd. now owns 1,489,870 shares of the scientific and technical instruments company’s stock valued at $116,046,000 after buying an additional 941,917 shares in the last quarter. JPMorgan Chase & Co. boosted its position in MKS Instruments by 70.6% during the 1st quarter. JPMorgan Chase & Co. now owns 1,214,934 shares of the scientific and technical instruments company’s stock valued at $113,050,000 after buying an additional 502,758 shares during the period. Ceredex Value Advisors LLC purchased a new stake in MKS Instruments during the 1st quarter valued at $28,115,000. First Trust Advisors LP grew its holdings in MKS Instruments by 760.5% in the 2nd quarter. First Trust Advisors LP now owns 319,605 shares of the scientific and technical instruments company’s stock worth $24,894,000 after acquiring an additional 282,464 shares during the last quarter. Finally, OppenheimerFunds Inc. grew its holdings in MKS Instruments by 38.6% in the 1st quarter. OppenheimerFunds Inc. now owns 893,041 shares of the scientific and technical instruments company’s stock worth $83,098,000 after acquiring an additional 248,736 shares during the last quarter. Institutional investors own 96.95% of the company’s stock.

Shares of MKS Instruments stock traded up $2.61 on Friday, reaching $93.79. 13,843 shares of the stock were exchanged, compared to its average volume of 418,014. The firm’s 50 day moving average is $79.88 and its 200-day moving average is $82.95. MKS Instruments has a one year low of $56.37 and a one year high of $103.86. The company has a debt-to-equity ratio of 0.48, a quick ratio of 3.12 and a current ratio of 4.80. The firm has a market cap of $4.95 billion, a PE ratio of 11.96, a P/E/G ratio of 1.88 and a beta of 1.46.

MKS Instruments (NASDAQ:MKSI) last announced its quarterly earnings data on Tuesday, July 30th. The scientific and technical instruments company reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. MKS Instruments had a net margin of 11.41% and a return on equity of 16.34%. The business had revenue of $474.11 million for the quarter, compared to analysts’ expectations of $483.27 million. During the same period last year, the firm posted $2.33 earnings per share. The firm’s quarterly revenue was down 17.3% compared to the same quarter last year. On average, equities research analysts expect that MKS Instruments will post 4.03 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, September 6th. Shareholders of record on Monday, August 26th were issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 0.85%. The ex-dividend date of this dividend was Friday, August 23rd. MKS Instruments’s payout ratio is 10.22%.

About MKS Instruments

MKS Instruments, Inc provides instruments, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes worldwide. It operates through two segments, Vacuum and Analysis, and Light and Motion. The Vacuum and Analysis segment offers analytical and control solutions, including gas analyzers, automation control products, I/O modules, automation software, and precision machined components and electromechanical assemblies; direct and indirect pressure measurement and integrated process solutions; and materials delivery solutions comprising flow and valve technologies, as well as integrated pressure measurement and control subsystems to provide customers with control capabilities that are optimized for a given application.

Further Reading: Market Perform

Analyst Recommendations for MKS Instruments (NASDAQ:MKSI)

Receive News & Ratings for MKS Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS Instruments and related companies with MarketBeat.com's FREE daily email newsletter.